Syra Health (NASDAQ:SYRA – Get Free Report) is expected to announce its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect Syra Health to announce earnings of ($0.09) per share and revenue of $2.20 million for the quarter. Interested persons may visit the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 4:00 PM ET.
Syra Health (NASDAQ:SYRA – Get Free Report) last released its earnings results on Tuesday, August 11th. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.11. The business had revenue of $2.39 million during the quarter, compared to analysts’ expectations of $2.20 million. Syra Health had a negative net margin of 54.90% and a negative return on equity of 131.94%.
Syra Health Stock Up 28.6%
Shares of NASDAQ SYRA traded up $0.21 during midday trading on Monday, hitting $0.94. The stock had a trading volume of 12,561 shares, compared to its average volume of 41,074. The stock has a 50 day simple moving average of $0.87 and a 200-day simple moving average of $0.52. The company has a market capitalization of $13.02 million, a PE ratio of -1.45 and a beta of 2.91. Syra Health has a 1 year low of $0.06 and a 1 year high of $1.15.
Syra Health Company Profile
Syra Health Corp. is a healthcare technology and services company focused on improving access, delivery and outcomes across the U.S. healthcare system. The company develops solutions for behavioral and mental health, population health management, healthcare education and workforce needs.
Its offerings are designed to support healthcare providers, government agencies, employers and other organizations. Syra Health combines technology, data and professional services to assist with areas such as care coordination, health education, clinical workforce development, behavioral health programs and population health initiatives.
Based in Carmel, Indiana, Syra Health was established in the early 2020s and serves clients in the United States.
See Also
- Five stocks we like better than Syra Health
- 3 Tech Stocks Boosting Buyback Capacity in the Face of the Sector’s Recent Tumble
- Strategy Pauses Bitcoin Buys to Focus on Preferred Stock Buybacks
- Uranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?
- Royal Caribbean Buys the Beach as Norwegian Fixes the Ship
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.
